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The vaccinia virus E3 protein is an important intracellular modulator of innate immunity that can be
split into distinct halves. The C terminus contains a well defined dsRNA-binding domain, whereas
the N terminus contains a Z-DNA-binding domain, and both domains are required for virulence. In
this study, we investigated whether the E3 Z-DNA-binding domain functions by sequestering
cytoplasmic dsDNA thereby preventing the induction of type I interferon (IFN). In line with this
hypothesis, expression of E3 ablated both IFN-b expression and NF-kB activity in response to the
dsDNA, poly(dA–dT). However, surprisingly, the ability of E3 to block poly(dA–dT) signalling was
independent of the N terminus, whereas the dsRNA-binding domain was essential, suggesting
that the Z-DNA-binding domain does not bind immunostimulatory dsDNA. This was confirmed by
the failure of E3 to co-precipitate with biotinylated dsDNA, whereas the recruitment of several
cytoplasmic DNA-binding proteins could be detected. Recently, AT-rich dsDNA was reported to
be transcribed into 59-triphosphate poly(A-U) RNA by RNA polymerase III, which then activates
retinoic acid-inducible gene I (RIG-I). Consistent with this, RNA from poly(dA–dT) transfected
cells induced IFN-b and expression of the E3 dsRNA-binding domain was sufficient to ablate this
response. Given the well documented function of the E3 dsRNA-binding domain we propose that
E3 blocks signalling in response to poly(dA–dT) by binding to transcribed poly(A-U) RNA
preventing RIG-I activation. This report describes a DNA virus-encoded inhibitor of the RNA
polymerase III-dsDNA-sensing pathway and extends our knowledge of E3 as a modulator of
innate immunity.
INTRODUCTION
Vaccinia virus (VACV) is the prototypical member of the
genus Orthopoxvirus (OPV). As with all poxviruses, VACV
is a large dsDNA virus that replicates within the cytoplasm
of infected cells (Moss, 2007). This replication strategy
results in the production of immunostimulatory nucleic
acids that have the potential to activate the innate immune
response via pattern-recognition receptors (PRRs). Not
surprisingly, VACV therefore encodes many intracellular
and extracellular modulators of innate immunity that serve
to prevent the host from mounting an effective immune
response to infection (for examples see Alcami & Smith,
1992; Carroll et al., 1993; Chen et al., 2008; Gedey et al.,
2006; Reading et al., 2003; Symons et al., 1995; for reviews
see Perdiguero & Esteban, 2009; Seet et al. 2003).
Self and non-self cytoplasmic dsDNA induces the expres-
sion of type I interferon (IFN) and NF-kB regulated genes
independently of Toll-like receptor 9 (TLR9) (Ishii et al.,
2006). However, the signalling pathways involved in this
process are poorly understood. The DNA-dependent
activator of IFN regulatory factors, DAI (also known as
ZBP1), was one candidate for the activation of IFN
signalling in response to dsDNA in certain cell types
(Takaoka et al., 2007). DAI contains two Z-DNA-binding
domains that bind dsDNA in a sequence-independent
manner. Once bound to dsDNA, DAI is thought to recruit
TANK-binding kinase 1 (TBK1) and IFN regulatory factor
3 (IRF3). IRF3 is then activated and translocates to the
nucleus, resulting in the induction of type I IFN (Takaoka
et al., 2007). In addition, DAI also recruits receptor-
interacting protein kinases, RIP1 and RIP3, through RIP
homotypic interaction motif-dependent interactions,
resulting in the activation of NF-kB (Kaiser et al., 2008).
However, other dsDNA sensors must exist because murine
embryonic fibroblasts (MEFs) lacking DAI still respond
normally to intracellular dsDNA (Wang et al., 2008).
Indeed, recent work has identified absent in melanoma 2
(AIM2) (Burckstummer et al., 2009; Fernandes-Alnemri
et al., 2009; Hornung et al., 2009; Roberts et al., 2009) and
RNA polymerase III (Ablasser et al., 2009; Chiu et al., 2009)
as two further dsDNA sensors.
As a consequence of its cytoplasmic replication it is probable
that VACV will encode inhibitors of cytosolic dsDNA
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protein that is highly conserved among OPVs and is
expressed early during infection localizing to both the
cytoplasm and nucleus (Watson et al., 1991; Yuwen et al.,
1993). E3 is important for VACV resistance to IFN, and can
be split into distinct N- and C-terminal halves. The C
terminus of E3 contains a dsRNA-binding domain that
servestosequesterdsRNAproducedduringviralreplication,
thereby preventing the activation of protein kinase R (PKR)
and RNase L, as well as, the activation of IRF3 (Chang &
Jacobs, 1993; Chang et al., 1992, 1995; Watson et al., 1991;
Xiang et al., 2002). Consequently, the dsRNA-binding
domain is important for the IFN resistant phenotype of
VACV (Brandt & Jacobs, 2001; Chang et al., 1995).
The E3 N terminus, on the other hand, contains a region
with amino acid similarity to the Z-DNA-binding domain
of DAI (Takaoka et al., 2007). The biological significance of
this similarity is poorly understood; however, the N
terminus is required for full VACV virulence (Brandt
et al., 2005; Brandt & Jacobs, 2001). Interestingly, the Z-
DNA-binding domain of DAI and another Z-DNA-
binding protein, adenosine deaminase 1 (ADAR1), can
substitute for the E3 N terminus in promoting VACV
virulence (Kim et al., 2003). Furthermore, mutation of
residues in the putative Z-DNA-binding domain of E3
analogous to those involved in contacting Z-DNA in
ADAR1 and DAI reduced VACV virulence (Kim et al.,
2003), suggesting that the E3 N terminus functions by
binding dsDNA. Intriguingly, expression of full-length E3
was reported to reduce IFN-b expression in response to the
dsDNA species poly(dA–dT) in MEFs (Wang et al., 2008).
However, the role of the N terminus in this phenotype was
not investigated. These observations, coupled with reports
that DAI functions as a PRR prompted us to investigate
whether the E3 Z-DNA-binding domain antagonizes
intracellular dsDNA PRRs by sequestering dsDNA.
RESULTS
Transfection of poly(dA–dT) induces IFN-b in a
dose-dependent manner independently of TLR9
The dsDNA, poly(dA–dT), is a potent inducer of type I
IFN following the transfection of MEFs (Ishii et al., 2006),
and E3 can inhibit IFN-b expression in response to
poly(dA–dT) (Marq et al., 2009; Wang et al., 2008). For
consistency with previous reports we therefore used
poly(dA–dT) in this study. Initially, a suitable reporter
assay system in which the role of the E3 N terminus in
blocking dsDNA signalling could be tested was developed
by transfecting 293T cells with an IFN-b reporter and
titrating increasing doses of poly(dA–dT). In accordance
with previous reports, poly(dA–dT) induced IFN-b
reporter activity in a dose-dependent manner (Fig. 1a).
293T cells express low levels of TLR9, which detects
extracellular unmethylated CpG DNA (Hemmi et al.,
2000). Although, it seems unlikely that poly(dA–dT) would
be a natural ligand for TLR9 it was necessary to
demonstrate that induction of IFN-b by poly(dA–dT)
was TLR9 independent. Accordingly, 293T cells were
transfected with poly(dA–dT) or, alternatively, poly(dA–
dT) was added to the culture medium in the absence of
transfection reagent (polyethylenimine, PEI) and the effects
upon IFN-b reporter activity were determined.
Transfection of poly(dA–dT) led to a 75-fold activation
of IFN-b reporter activity relative to the mock control.
However, this effect was completely ablated when poly(dA–
dT) was added to the culture medium in the absence of
transfection reagent (Fig. 1b). These results, therefore,
confirm that poly(dA–dT) is a potent stimulator of an
intracellular dsDNA PRR.
The E3 dsRNA-binding domain inhibits IFN-b
expression in response to poly(dA–dT)
independently of the E3 Z-DNA-binding domain
Next, the ability of E3 to block IFN-b reporter activity in
response to the transfection of poly(dA–dT) was tested.
293T cells were co-transfected with the IFN-b reporter
together with expression plasmids encoding N-terminally
Fig. 1. Poly(dA–dT) induces IFN-b reporter activity in a dose-
dependent and TLR9-independent manner. 293T cells were co-
transfected with pRL-TK and IFN-b reporter plasmids overnight.
(a) The cells were then transfected with the indicated amounts of
poly(dA–dT) for 24 h prior to the harvesting of cells for dual
luciferase reporter assay. (b) 200 ng poly(dA–dT) was added to
the cells in the presence, or absence, of the transfection reagent
PEI, as indicated, and the cells then lysed 24 h later for dual
luciferase reporter assay. Errors bars indicate the mean±SEM.
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N-terminal 83 aa (D83N) or the C-terminal 26 aa (D26C)
(Fig. 2a). Transfection of poly(dA–dT) and empty vector
control (pcDNA4) resulted in a 13-fold induction of IFN-b
luciferase activity, and in agreement with earlier reports
(Marq et al., 2009; Wang et al., 2008), expression of full-
length E3 led to an almost complete ablation of IFN-b
reporter activity. However, contrary to what was expected,
D83N lacking the Z-DNA-binding domain was almost as
efficient as full-length E3 in blocking IFN-b. In contrast,
removal of the C-terminal 26 aa, which prevents E3
binding dsRNA (Chang & Jacobs, 1993), removed the
inhibitory activity and was comparable to the empty vector
control (Fig. 2b). Similar results were also obtained in
HeLa cells confirming these effects were not cell type
specific (Fig. 2c). Furthermore, the inability of the Z-DNA-
binding domain to block poly(dA–dT) signalling was
confirmed using a different set of vectors expressing either
the Z-DNA-binding (aa 1–83) or dsRNA-binding (D83N,
aa 84–190) domains of E3 (Fig. 2a, d) both of which are
expressed at equivalent levels (Fig. 2e and data not shown).
The failure of D26C to inhibit IFN-b reporter activity was
not due to an absence of protein because immunoblotting
with anti-FLAG monoclonal antibody (mAb) confirmed
protein expression (Fig. 2e). Furthermore, despite being
relatively unstable in comparison to full-length E3 and
D26C, the D83N deletion mutant is still a potent inhibitor
of poly(dA–dT) signalling.
The ability of wild-type and mutant E3 to block IFN-b
secretion from 293T cells induced by poly(dA–dT) was
tested by ELISA. In agreement with the luciferase data
transfection of poly(dA–dT) induced IFN-b secretion in
those cells transfected with pcDNA4 and this was blocked
following expression of either E3 or D83N (Fig. 3a).
However, this inhibitory effect was lost following the
expression of D26C, confirming that the dsRNA, but not Z-
DNA-binding domain, is important for the inhibition of
poly(dA–dT) signalling. The ability of E3 to block IFN-
stimulated response element (ISRE) reporter activity in
response to poly(dA–dT) was examined next. It was
hypothesized that if the E3 dsRNA-binding domain was
inhibiting IFN-b production in response to poly(dA–dT),
an indirect inhibition of ISRE activity should be observed.
In agreement with the ELISA data (Fig. 3a), transfection of
poly(dA–dT) led to a modest threefold stimulation of ISRE
activity, whereas both full-length E3 and D83N produced a
statistically significant inhibition (Fig. 3b). This effect was
completely ablated in those cells expressing E3 D26C,
consistent with the IFN-b reporter data. Moreover, E3 was
unable to inhibit ISRE reporter activity in response to IFN-
a stimulation, confirming that the E3-mediated reduction
in ISRE activity was not a consequence of E3 directly
modulating the Jak/STAT signalling pathway (Fig. 3c).
To extend these observations we tested whether E3
associated with cytoplasmic biotinylated dsDNA by co-
Fig. 2. E3 inhibits IFN-b production in
response to poly(dA–dT) via its C-terminal
dsRNA-binding domain. (a) Schematic of full-
length E3 and mutants in the C-terminal
dsRNA-binding and N-terminal Z-DNA-
binding domains. Amino acid positions are
indicated at the top of full-length E3. (b) 293T
and (c) HeLa cells were co-transfected with
pRL-TK and IFN-b reporter plasmids together
with pcDNA4, E3, D26C and D83N plasmids
overnight. These cells were then transfected
with 200 ng poly(dA–dT) and lysed for dual
luciferase reporter assay after 24 h. (d) HeLa
cells were co-transfected with pRL-TK and
IFN-b reporter plasmids together with
pcDNA4, E3, E3 dsRNA-binding domain and
E3 Z-DNA-binding domain plasmids overnight
and treated as described for (b) and (c). (e)
293T cells were transfected with pcDNA4, E3,
D26C and D83N plasmids overnight. Cell
lysates were then resolved by SDS-PAGE
(12% gel) and immunoblotted using anti-
FLAG mAb (1:1000). Anti-a-tubulin mAb
(1:5000) served as a protein loading control.
The positions of molecular mass markers in
kDa are indicated.
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blotting or silver staining (Fig. 4). In contrast, the
interaction of several cytoplasmic dsDNA-binding proteins
with biotinylated DNA was detected and this was
unaffected by the expression of E3 (Fig. 4 upper panel).
293T cells transfected with a plasmid expressing FLAG-
tagged VACV protein B14 served as a negative control. The
B14 protein binds IKKb and inhibits NF-kB activation
(Chen et al., 2008) and would not be expected to bind
dsDNA. In line with this, no binding of B14 to biotinylated
dsDNA was detected (Fig. 4). Therefore, contrary to what
was expected, the E3 dsRNA-binding domain is an
inhibitor of the poly(dA–dT) signalling pathway, whilst
the E3 Z-DNA-binding domain is entirely dispensable.
The E3 dsRNA-binding domain inhibits NF-kB
activity in response to poly(dA–dT)
The transfection of dsDNA induces not only IFN-b
expression but also NF-kB activation (Kaiser et al., 2008;
Takaoka et al., 2007) and, therefore, the ability of E3 to
block NF-kB reporter activity in response to poly(dA–dT)
was investigated. Transfection of poly(dA–dT) resulted in a
fivefold activation of luciferase activity in cells transfected
with the empty vector control plasmid and this was blocked
in cells expressing either full-length E3 or D83N. In contrast,
D26C was not inhibitory (Fig. 5a). This is consistent with
the E3 dsRNA-binding domain being crucial for E3 to block
signalling in response to poly(dA–dT), whilst the Z-DNA-
binding domain is not required (Figs 2 and 3).
Several pro-inflammatory signalling pathways converge
on the IKK complex, resulting in the phosphorylation of
IkBa and the translocation of p65 and p50 homo- and
Fig. 3. E3 inhibits the secretion of IFN-b and subsequent ISRE
activation in response to poly(dA–dT). (a) 293T cells were
transfected with pcDNA4, E3, D26C and D83N plasmids
overnight. The cells were then transfected with 750 ng poly(dA–
dT) for 24 h and IFN-b in the cell supernatant was measured by
ELISA. (b, c) 293T cells were co-transfected with pRL-TK and
ISRE reporter plasmids together with pcDNA4, E3, D26C and
D83N plasmids overnight. The cells were then either (b)
transfected with 200 ng poly(dA–dT) for 24 h or (c) stimulated
with 500 U IFN-a ml
”1 for 7 h prior to the harvesting of cells for
dual luciferase reporter assay. Error bars indicate the mean±SEM
(*P,0.05, **P,0.01).
Fig. 4. E3 does not bind cytoplasmic biotinylated dsDNA. 293T
cells were transfected with plasmids expressing either FLAG-
tagged B14 or E3 or an empty vector control (pcDNA4). The
following day the cells were transfected with 20 mg biotinylated
dsDNA and 4 h post-transfection the cells were lysed and the
biotinylated dsDNA was pulled down from the cytoplasmic fraction
using 100 ml streptavidin agarose. The pulled down fractions were
then resolved on NuPAGE 4–12% Bis-Tris pre-cast gels and then
either silver stained (upper panel) or immunoblotted using anti-
FLAG mAb (1:1000) (lower panel). The positions of molecular
mass markers in kDa are indicated.
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Since E3 can block NF-kB activity in response to poly(dA–
dT) it was important to determine whether E3 was a broad
spectrum NF-kB inhibitor or whether inhibition was
specific to the poly(dA–dT)-sensing pathway. To address
this, 293T cells were co-transfected with the NF-kB
reporter, and E3 expression plasmids, and then treated
with tumour necrosis factor-alpha (TNF-a). Treatment of
the control cells with TNF-a induced a strong induction of
NF-kB reporter activity. However, in contrast to poly(dA–
dT) stimulation, neither full-length E3 nor D83N caused
statistically significant repression of this activity (compare
Fig. 5a against 5b). Similar results were obtained when
using IL-1b to activate NF-kB (Fig. 5c). These data confirm
that E3 is not a broad spectrum NF-kB inhibitor.
E3 is an inhibitor of the RNA polymerase III
cytoplasmic dsDNA signalling pathway
Recently, RNA polymerase III was described as a novel
cytoplasmic PRR for AT-rich dsDNA (Ablasser et al., 2009;
Chiu et al., 2009). Specifically, RNA polymerase III
transcribes poly(dA–dT), resulting in the production of
59-triphosphate poly(A-U) RNA. This RNA then serves as a
pathogen-associated molecular pattern (PAMP) for the
PRR, retinoic acid-inducible gene I (RIG-I), resulting in
IFN-b production (Yoneyama et al., 2004). Consistent with
these reports, transfection of total RNA harvested from
poly(dA–dT) transfected cells resulted in IFN-b mRNA
upregulation. Treatment of the RNA preparation with
RNase A under low salt conditions, which results in the
cleavage of dsRNA, ablated this induction (Fig. 6a),
whereas treatment with DNase I did not (Fig. 6b). The
specificity of the enzymic reactions was confirmed by
treating the dsRNA analogue, poly(I:C), or the dsDNA,
poly(dA–dT), with either RNase A or DNase I, respectively,
under the same conditions as described above (Fig. 6c).
The binding of 59-triphosphate dsRNA by RIG-I results in
the recruitment of the adaptor protein, IFN-b promoter
stimulator 1 (IPS-1), which then acts as a scaffold for the
activation of both IRF3 and NF-kB (Kawai et al., 2005).
Indeed, transfection of the total RNA, which induced IFN-
b, resulted in both ISG56.1 (Fig. 7a) and NF-kB (Fig. 7b)
stimulation in 293T cells. ISG56.1 is a transcriptional target
for IRF3 and is, therefore, a good readout for IRF3-specific
activation (Grandvaux et al., 2002). However, this
luciferase activity was ablated by E3, and the C-terminal
dsRNA-binding domain was sufficient to mediate this
inhibition (Fig. 7a, b). Furthermore, the level of luciferase
activity obtained following transfection of the total RNA
and subsequent inhibition by E3 was in line with that
obtained when transfecting the synthetic dsRNA, poly(I:C),
which is known to engage RIG-I (Fig. 7c). These results,
therefore, support the conclusion that the immunostimu-
latory RNA engages the RIG-I signalling pathway and that
E3 inhibits this process.
DISCUSSION
The innate immune response represents the first line of
defence against pathogenic micro-organisms. PRRs serve to
detect conserved PAMPs. Once engaged PRRs signal via
adaptor proteins to activate NF-kB and IRF3, resulting in
the secretion of type I IFN and pro-inflammatory cytokines
and chemokines (Randall & Goodbourn, 2008). The VACV
E3 protein is a well known inhibitor of dsRNA PRRs and
antiviral molecules. It was proposed that E3 may also
function as an inhibitor of intracellular dsDNA PRRs by
sequestering dsDNA via the N-terminal Z-DNA-binding
domain (Wang et al., 2008). However, this hypothesis is
based on amino acid similarity to the cytoplasmic dsDNA
sensor, DAI, and has never formally been demonstrated. In
agreement with recent reports we confirm that E3 is a
Fig. 5. The E3 dsRNA-binding domain inhibits NF-kB reporter
activity in response to poly(dA–dT). 293T cells were co-
transfected with pRL-TK and NF-kB reporter plasmids together
with pcDNA4, E3, D26C and D83N plasmids overnight. The cells
were then either (a) transfected with 200 ng poly(dA–dT) for 24 h
or stimulated with (b) 250 ng TNF-a ml
”1 or (c) 100 ng IL-1b ml
”1
for 7 h prior to the harvesting of cells for dual luciferase reporter
assay. Error bars indicate the mean±SEM (*P,0.05).
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dsDNA, poly(dA–dT) (Marq et al., 2009; Wang et al.,
2008). Using E3 deletion mutants we show that the
assumption that this inhibition is mediated via the Z-
DNA-binding domain is untrue. Indeed, the ability of E3
to block signalling in response to poly(dA–dT) maps
entirely to the C-terminal dsRNA-binding domain. The
inability of the E3 Z-DNA-binding domain to bind
cytoplasmic dsDNA is also supported by pull-down assays
in which biotinylated dsDNA could recruit other DNA-
binding proteins, but not E3. This indicates that the
virulence promoting function of the E3 N terminus is not
due to binding of cytoplasmic dsDNA. Given the amino
acid similarity of the E3 and DAI Z-DNA-binding domains
these results also question whether the primary function of
DAI is as a cytoplasmic PRR.
Whilst this study was ongoing, RNA polymerase III was
described as a novel cytoplasmic PRR for dsDNA. RNA
polymerase III was found to transcribe AT-rich DNA,
resulting in the production of 59-triphosphate poly(A-U)
RNA, which then served as a PAMP for RIG-I (Ablasser
et al., 2009; Chiu et al., 2009). These reports, therefore,
perfectly explain both the observations from our group,
and others, that the E3 dsRNA-binding domain can inhibit
poly(dA–dT) signalling (Marq et al., 2009). Indeed, we
have confirmed that the transfection of poly(dA–dT)
results in the production of an immunostimulatory RNA,
which activates both IRF3 and NF-kB, thereby inducing
type I IFN. Furthermore, expression of the E3 dsRNA-
binding domain is sufficient to antagonize this response,
suggesting that E3 is specifically binding the immunosti-
mulatory RNA preventing activation of divergent signalling
pathways downstream of the RIG-I receptor complex. In
addition to the RNA polymerase III-sensing pathway, RIG-
I may bind directly to dsDNA (Choi et al., 2009). However,
we found no evidence to support E3 associating with
dsDNA, ruling out the possibility that the E3 dsRNA-
binding domain associates directly with DNA. We
conclude that E3 is a novel inhibitor of the RNA
polymerase III AT-rich DNA-sensing pathway and that
this is mediated via the well characterized function of E3
binding to dsRNA. This might be important for VACV
replication since the VACV genome is AT-rich and,
therefore, one would envisage VACV being particularly
sensitive to sensing via RNA polymerase III (Moss, 2007).
This is difficult to test directly, however, due to the
essential function of RNA polymerase III within cells.
Whilst data presented in this report helps further clarify
why VACV lacking the C terminus of the E3 protein
presents with such an avirulent phenotype, the function of
the N terminus in virulence remains unclear (Brandt &
Jacobs, 2001; Chang et al., 1995). Although our studies
suggest that E3 does not bind immunostimulatory dsDNA,
which is likely to reside within a right-handed B-DNA
conformation, we cannot rule out that the E3 N terminus
associates with left-handed Z-DNA. The formation of
Fig. 6. Transfection of total RNA harvested
from poly(dA–dT) transfected cells results in
IFN-b expression. 293T cells were transfected
with 12 mg total RNA extracted from 293T
cells that had been transfected with 12 mg
poly(dA–dT) for 24 h. Induction of IFN-b
mRNA was confirmed to be specific for an
immunostimulatory RNA species by treating
total RNA with either (a) 0.1 mg RNase A ml
”1
or (b) 0.1 U amplification grade DNase I ml
”1.
Total RNA was then extracted 24 h post-
transfection and real-time qPCR performed for
IFN-b. These data were normalized against
GAPDH mRNA levels. Error bars indicate the
mean±SEM (*P,0.05). (c) Cleavage of dsRNA
or dsDNA by treatment with either RNase A or
DNase I, respectively, was confirmed by
treating poly(I:C) and poly(dA–dT) under the
same conditions as for (a) and (b), respect-
ively. The samples were then resolved on a
1% agarose gel and stained using ethidium
bromide.
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DNA, resulting in negative supercoiling behind the
transcription complex. Furthermore, sequences that favour
the formation of Z-DNA may be a common feature of
most gene transcription start sites (Rich & Zhang, 2003). It
is, therefore, interesting to speculate that the importance of
the E3 N terminus and other Z-DNA-binding proteins
might lie in regulating cellular transcription. Indeed, E3 has
been reported to upregulate the transcription of certain
genes (Kwon & Rich, 2005), although, this remains
controversial (Langland et al., 2006). The mechanism by
which the E3 N terminus promotes virulence remains
unknown.
In summary, our results extend our knowledge of E3 as an
inhibitor of innate immunity and provide an example of a
dsDNA virus encoding an inhibitor of the recently
described RNA polymerase III-dependent sensing of
dsDNA in innate immunity.
METHODS
Cell culture. Human embryonic kidney 293T and HeLa cells were
cultured in Dulbecco’s modified Eagle’s medium (DMEM; Gibco)
supplemented with 10% fetal bovine serum, 100 U penicillin ml
21 and
100 mg streptomycin ml
21 and 2 mM L-glutamine (Sigma-Aldrich).
Plasmids. N-terminal FLAG-tagged E3, D26C and D83N were
generated by PCR using the E3L gene from VACV strain Western
Reserve (WR) as template. The PCR products were then cloned into
the multiple cloning site of pcDNA4 TO (Invitrogen). The IFN-b,
ISRE, IFN-stimulated gene 56.1 (IRF3) and NF-kB reporters, which
drive firefly luciferase expression, and the Renilla luciferase control
plasmid (pRL-TK) have been described previously (Chen et al., 2008).
Reporter assays. 293T cells were seeded into 96-well tissue culture
plates overnight prior to transfection with 70 ng of the indicated
reporter plasmids, 10 ng pRL-TK and 70 ng of the appropriate E3
expression plasmid or empty vector control (pcDNA4) as indicated
using PEI (Park Scientific). Following incubation overnight cells were
stimulated as follows. For dsDNA stimulation, 293T cells were
transfected with the indicated amounts of poly(dA–dT) (Sigma-
Aldrich) for 24 h. For IFN-a, TNF-a and IL-1b (Peprotech)
stimulations the cells were treated at the indicated concentrations
for 7 h. Once the stimulation was complete cell lysates were harvested
using passive lysis buffer and dual luciferase reporter assays were
performed following the manufacturer’s instructions (Promega).
Relative luciferase activity was determined by normalizing the firefly
luciferase data against the respective Renilla luciferase control. In all
cases, data are from one of two to four independent experiments with
similar qualitative results. Data from experiments performed in
triplicate are expressed as means±SEM. Statistical analysis was
performed by an F-test to determine equal or unequal variance
followed by a Student’s t-test where appropriate.
ELISA. Levels of IFN-b in the supernatant of 293T cells were
measured using a human IFN-b-specific ELISA kit (PBL Biomedical
Laboratories) following the manufacturer’s instructions.
DNA pull-down assay and immunoblotting. DNA pull-down
assays were performed by transfecting 293T cells with biotinylated
dsDNA (Integrated DNA Technologies) using PEI. Following 4 h
incubation, cells were lysed on ice using buffer containing 10 mM
Tris/HCl, pH 8, 0.1% NP-40, 10 mM MgCl2 and the cytoplasmic
fraction was isolated. This was incubated with streptavidin agarose for
2 h and the beads were then washed three times with chilled PBS
prior to analysis by both immunoblotting and silver staining
(Invitrogen).
Immunoblotting was performed as described previously (Chen et al.,
2008) using mouse anti-FLAG (Sigma-Aldrich) and mouse anti-a-
tubulin primary mAbs (Upstate).
Fig. 7. The E3 dsRNA-binding domain blocks IRF3 and NF-kB
activation in response to poly(dA–dT) transcribed RNA. 293T cells
were co-transfected with pRL-TK and either (a) ISG56.1 or (b)
NF-kB reporter plasmids together with plasmids expressing either
E3 or the E3 dsRNA-binding domain or the empty vector control
(pcDNA4) overnight. The cells were then transfected with 1 mg
total RNA extracted from 293Ts that had been transfected with
12 mg poly(dA–dT) for 24 h. At 24 h post-transfection, cells were
lysed for dual luciferase reporter assay. (c) As a positive control
293T cells were co-transfected with the NF-kB reporter plasmid
as described for (b) and the following day were transfected with
800 ng poly(I:C) for 24 h prior to harvesting of cells for dual
luciferase reporter assay. Error bars indicate the mean±SEM
(*P,0.05, **P,0.01, ***P,0.001).
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RNA was isolated using TRIzol reagent (Invitrogen) following the
manufacturer’s instructions. Nucleic acids were treated either with
RNase A using the conditions described previously (Chiu et al., 2009)
or with amplification grade DNase I following the manufacturer’s
instructions (Invitrogen).
Real-time qPCR. RNA was reverse transcribed using Superscript III
Reverse Transcriptase (Invitrogen) following the manufacturer’s
instructions. Real-time qPCR was performed using FAST SYBR green
master mix (Applied Biosystems) on a 7900HT thermocycler
(Applied Biosystems) and data were analysed using the relative
quantification manager software. Real-time qPCR for GAPDH was
used to normalize all data.
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